UPDATED Apr 22, 2023
Stocks with a market cap under US$50M.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
LO91VBI Vaccines | US$0.25 | -96.7% | n/a | US$28.2m | US$4.51 | PS26x | E36.5% | n/a | ||
LO9AVBI Vaccines | US$2.77 | 6.1% | -92.6% | US$27.5m | US$28.61 | PS25.4x | E36.5% | n/a | ||
A89Adocia | €2.81 | -3.3% | -38.4% | €25.0m | €8.62 | PS1.4x | E98.9% | n/a | ||
78FFreeline Therapeutics Holdings | US$0.33 | -11.2% | -59.0% | US$25.7m | US$1.27 | PB0.5x | E34.3% | n/a | ||
8RKLabiana Health | €2.76 | -4.2% | n/a | €21.7m | n/a | n/a | n/a | n/a | ||
SBXSynBiotic | €5.54 | -18.8% | -70.3% | €20.4m | €46.00 | PS2.2x | E123.0% | n/a | ||
SBXSynBiotic | €5.42 | -23.0% | -71.5% | €20.4m | €45.00 | PS2.2x | E123.0% | n/a | ||
SBXSynBiotic | €5.54 | -19.9% | -71.0% | €20.4m | €46.00 | PS2.2x | E123.0% | n/a | ||
BTPCActive Biotech | kr0.062 | -9.3% | -23.3% | kr214.8m | n/a | PB6.2x | E119.6% | n/a | ||
A1PAcasti Pharma | US$0.36 | 0% | -64.1% | US$20.7m | US$1.80 | PB0.2x | E-18.3% | n/a | ||
6ZYZynerba Pharmaceuticals | US$0.38 | 5.0% | -72.5% | US$20.6m | US$5.05 | PB0.4x | E59.1% | n/a | ||
P731Medexus Pharmaceuticals | CA$0.95 | -5.9% | -57.2% | CA$27.6m | CA$2.29 | PB1.3x | E12.3% | n/a | ||
HOB0YourWay Cannabis Brands | CA$0.063 | 0% | -61.3% | CA$23.2m | n/a | PE6x | n/a | n/a | ||
E8LGeoVax Labs | US$0.58 | -7.0% | -34.1% | US$16.9m | US$5.11 | PS206.7x | E32.7% | n/a | ||
EO7Endo International | US$0.09 | 28.6% | -95.7% | US$16.5m | n/a | PE-0.006x | n/a | n/a | ||
NV3PNanoViricides | US$1.20 | 11.1% | -20.7% | US$16.0m | US$4.58 | PB0.8x | S87.5% | n/a | ||
PI2Proteome Sciences | UK£0.031 | 3.3% | -15.1% | UK£12.5m | n/a | PE9.4x | n/a | n/a | ||
2RH0RedHill Biopharma | US$2.50 | -9.4% | -96.6% | US$11.6m | US$36.36 | PE-0.1x | E50.8% | n/a | ||
8LYOncoZenge | kr0.80 | 13.8% | 327.2% | kr111.3m | n/a | PB3.3x | E41.9% | n/a | ||
2PUPulmatrix | US$2.47 | -3.1% | -51.9% | US$10.5m | US$8.58 | PS1.7x | E35.7% | n/a | ||
P52Newbury Pharmaceuticals | kr0.47 | -10.2% | -44.3% | kr107.4m | n/a | PS15.4x | E7.0% | n/a | ||
A1V0Aptorum Group | US$3.08 | 0% | -75.4% | US$9.9m | US$127.68 | PS6.9x | E19.3% | n/a | ||
78DAlzinova | kr0.20 | -10.3% | -11.5% | kr90.4m | n/a | PS5.4x | E134.1% | n/a | ||
AY20Aytu BioPharma | US$3.28 | 0% | -81.8% | US$8.4m | US$103.86 | PB0.2x | E67.4% | n/a |